Meeting Coverage
WCN
World Congress of Neurology
VIENNA -- Pooled phase III study results on eslicarbazepine acetate, a prodrug for S(+)-liscarbazepine, showed that the drug outperformed placebo as add-on therapy for partial-onset seizures in adults, a researcher said here.
